The activation of D2 and D3 receptor subtypes inhibits pathways mediating primary afferent depolarization (PAD) in the mouse spinal cord

被引:3
|
作者
Milla-Cruz, Jonathan J. [1 ]
Mena-Avila, Elvia [1 ]
Calvo, Jorge R. [1 ]
Hochman, Shawn [2 ]
Villalon, Carlos M. [3 ]
Quevedo, Jorge N. [1 ]
机构
[1] Inst Politecn Nacl, Dept Fisiol Biofis & Neurociencias, Ctr Invest & Estudios Avanzados, Mexico City, DF, Mexico
[2] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA
[3] Inst Politecn Nacl, Dept Farmacobiol, Ctr Invest & Estudios Avanzados, Mexico City, DF, Mexico
基金
美国国家卫生研究院;
关键词
Dopamine; Primary afferent depolarization; Spinal cord; Neuromodulation; Presynaptic inhibition; II MUSCLE AFFERENTS; DOPAMINE; RAT; TRANSMISSION; MONOAMINES; NEURONS; CAT;
D O I
10.1016/j.neulet.2020.135257
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Somatosensory information can be modulated at the spinal cord level by primary afferent depolarization (PAD), known to produce presynaptic inhibition (PSI) by decreasing neurotransmitter release through the activation of presynaptic ionotropic receptors. Descending monoaminergic systems also modulate somatosensory processing. We investigated the role of D-1 -like and D-2 -like receptors on pathways mediating PAD in the hemisected spinal cord of neonatal mice. We recorded low-threshold evoked dorsal root potentials (DRPs) and population monosynaptic responses as extracellular field potentials (EFPs). We used a paired-pulse conditioning-test protocol to assess homosynaptic and heterosynaptic depression of evoked EFPs to discriminate between dopaminergic effects on afferent synaptic efficacy and/or on pathways mediating PAD, respectively. DA (10 mu M) depressed low-threshold evoked DRPs by 43 %, with no effect on EFPs. These depressant effects on DRPs were mimicked by the D-2-like receptor agonist quinpirole (35 %). Moreover, by using selective antagonists at D-2-like receptors (encompassing the D-2, D-3, and D-4 subtypes), we found that the D-2 and D-3 receptor subtypes participate in the quinpirole depressant inhibitory effects of pathways mediating PAD.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Association of genetic ancestry with striatal dopamine D2/D3 receptor availability
    C E Wiers
    P C Towb
    C A Hodgkinson
    P-H Shen
    C Freeman
    G Miller
    E Lindgren
    E Shokri-Kojori
    Ş B Demiral
    S W Kim
    D Tomasi
    H Sun
    G-J Wang
    D Goldman
    N D Volkow
    Molecular Psychiatry, 2018, 23 : 1711 - 1716
  • [42] Markers of D2 and D3 receptor activity in vivo:: PET scan and prolactin
    Thomasson-Perret, Nitza
    Penelaud, Pierre-Francois
    Theron, David
    Gouttefangeas, Sylvie
    Mocaer, Elisabeth
    THERAPIE, 2008, 63 (03): : 237 - 242
  • [43] Talipexole variations as novel bitopic dopamine D2 and D3 receptor ligands
    Stank, Lars
    Frank, Annika
    Hagenow, Stefanie
    Stark, Holger
    MEDCHEMCOMM, 2019, 10 (11) : 1926 - 1929
  • [44] Dopamine D2/D3 receptor agonists produce antidepressant-like effects in the rat forced swim test through co-activation of both receptor subtypes
    Jutkiewicz, Emily M.
    Collins, Gregory T.
    Woods, James H.
    FASEB JOURNAL, 2008, 22
  • [45] Aromatic linker variations in novel dopamine D2 and D3 receptor ligands
    Di Biase, Cristian
    Leitzbach, Luisa
    Frank, Annika
    Zivkovic, Aleksandra
    Stark, Holger
    ARCHIV DER PHARMAZIE, 2024, 357 (08)
  • [46] Dopamine D3 receptor density and occupancy determined with selective D3 inhibitor and [11C]raclopride (D2/D3) PET.
    Wong, DF
    Gjedde, A
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 256P - 256P
  • [47] Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease
    Ryoo, HL
    Pierrotti, D
    Joyce, JN
    MOVEMENT DISORDERS, 1998, 13 (05) : 788 - 797
  • [48] MOLECULAR CHARACTERIZATION OF THE D2, D3, D4 DOPAMINE-RECEPTOR FAMILY
    CIVELLI, O
    NEUROPSYCHOPHARMACOLOGY, 1993, 9 (02) : S35 - S35
  • [49] Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists
    Boulay, D
    Depoortere, R
    Perrault, G
    Borrelli, E
    Sanger, DJ
    NEUROPHARMACOLOGY, 1999, 38 (09) : 1389 - 1396
  • [50] Signaling Pathways Leading to Phosphorylation of Akt and GSK-3β by Activation of Cloned Human and Rat Cerebral D2 and D3 Receptors
    la Cour, Clotilde Mannoury
    Salles, Marie-Josephe
    Pasteau, Valerie
    Millan, Mark J.
    MOLECULAR PHARMACOLOGY, 2011, 79 (01) : 91 - 105